THNR vs. OZEM ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Roundhill GLP-1 & Weight Loss ETF (OZEM)

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.17

Average Daily Volume

2,604

Number of Holdings ^*

15

* may have additional holdings in another (foreign) market

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.45

Average Daily Volume

38,199

Number of Holdings ^*

14

* may have additional holdings in another (foreign) market

Performance

Period	THNR	OZEM
30 Days	-11.49%	-10.50%
60 Days	-15.44%	-10.19%
90 Days	-16.31%	-10.75%
12 Months

9 Overlapping Holdings

	Symbol	Grade	Weight in THNR	Weight in OZEM	Overlap
	ALT	C	0.27%	4.44%	0.27%
	AMGN	D	5.07%	3.26%	3.26%
	AZN	F	4.62%	3.99%	3.99%
	LLY	F	14.71%	14.13%	14.13%
	NVO	D	13.16%	17.04%	13.16%
	OPK	B	0.21%	1.72%	0.21%
	PFE	F	5.03%	3.07%	3.07%
	TERN	F	0.14%	1.97%	0.14%
	VKTX	F	2.58%	3.39%	2.58%

THNR Overweight 6 Positions Relative to OZEM

	Symbol	Grade	Weight
	TMO	D	4.93%
	MRK	F	4.79%
	WST	C	4.49%
	TEVA	C	3.68%
	CTLT	D	2.0%
	HIMS	C	0.83%

THNR Underweight 5 Positions Relative to OZEM

	Symbol	Grade	Weight
	SRRK	B	-2.8%
	REGN	F	-2.4%
	RYTM	C	-2.3%
	TAK	D	-2.17%
	CORT	B	-1.77%

THNR: Top Represented Industries & Keywords

Industries: Drug Manufacturers - Major Biotechnology Drug Manufacturers - Specialty & Generic Conglomerates Diagnostics & Research Medical Instruments & Supplies

Keywords: Obesity Pharmaceutical Products S&P 500 Medicine Biopharmaceutical Cancer Asthma Diabetes Inflammation Medication Neuroscience Alzheimer's Disease Animal Health Antibiotics Biotechnology Cholesterol Depressive Disorder Drugs Health Products Hormones

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

Keywords: Biopharmaceutical Obesity Pharmaceutical Products Cancer Inflammation Biotechnology Diabetes Medicine Neuroscience S&P 500 Alzheimer's Disease Anemia Asthma Cholesterol Depressive Disorder Hormones Hypertension Life Sciences Major Depressive Disorder Medication